DICER1 and neoplasm: Similarly, in breast, liver, ovarian and bladder cancers, Dicer mRNA levels were significantly lower than in non-cancer tissues [15, 41, 44, 45]; a further association was noted between Dicer protein levels and tumor stage, decreased survival, and chemoresistance [15, 22, 29].